{"@id":"https://bioecon.ru/technology/car-t-potentiation-via-mitochondria/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://en.bioecon.ru/technology/car-t-potentiation-via-mitochondria/","json":"https://en.bioecon.ru/api/v1/technology/car-t-potentiation-via-mitochondria/index.json"},"id":"car-t-potentiation-via-mitochondria","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/johnson-johnson/","https://bioecon.ru/companies/san-diego-sa/","https://bioecon.ru/companies/impacfat/","https://bioecon.ru/companies/ingenio-risaralda-sa/","https://bioecon.ru/companies/wildtype/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/ipiranga-agroindustrial-sa/"]},"maturity":7,"name":"CAR-T Potentiation via Mitochondria","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"High-integrity mitochondrial isolation"},{"n":2,"title":"Microfluidic mitochondrial delivery"},{"n":3,"title":"Metabolic reprogramming verification"},{"n":4,"title":"Solid tumor persistence in vivo"}],"summary":"Transplantation of pristine, high-energy mitochondria isolated from healthy stem cells directly into engineered CAR-T cells, fundamentally rewiring their metabolic profile toward oxidative phosphorylation to prevent terminal exhaustion in immunosuppressive solid tumors.","url":"/technology/car-t-potentiation-via-mitochondria/","verified":"2026-11-22"}